NRT Share Price

Open 0.04 Change Price %
High 0.05 1 Day 0.01 25.00
Low 0.04 1 Week 0.00 0.00
Close 0.05 1 Month 0.00 0.00
Volume 42760 1 Year -0.06 -54.55
52 Week High 0.12
52 Week Low 0.04
NRT Important Levels
Resistance 2 0.06
Resistance 1 0.06
Pivot 0.05
Support 1 0.04
Support 2 0.04
ASX Australia Most Active Stocks
MEI 0.03 50.00%
MEI 0.03 50.00%
MEI 0.03 50.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TLS 4.44 -0.89%
TLS 4.44 -0.89%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
POH 0.02 100.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
MEI 0.03 50.00%
MEI 0.03 50.00%
MEI 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AGO 0.01 -50.00%
AGO 0.01 -50.00%
AGO 0.01 -50.00%
GDY 0.01 -50.00%
ESI 0.01 -50.00%
More..

Novogen Ltd (ASX: NRT)

NRT Technical Analysis 4
As on 29th May 2017 NRT Share Price closed @ 0.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.08 & Sell for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
NRT Target for May
1st Target up-side 0.06
2nd Target up-side 0.07
3rd Target up-side 0.08
1st Target down-side 0.04
2nd Target down-side 0.03
3rd Target down-side 0.02
NRT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.novogen.com
NRT Address
NRT
16 - 20 Edgeworth David Avenue
Level 1
Hornsby, NSW 2077
Australia
Phone: 61 2 9476 0344
Fax: 61 2 9476 0388
NRT Latest News
Novogen Limited (NVGN) Downgraded to "Hold" at Zacks Investment Research   The Cerbat Gem   - 29th May 17
Honing in on Shares of Novogen Limited (NASDAQ:NVGN)   Morgan Research   - 28th May 17
Novogen Limited (NVGN) Rating Lowered to Hold at Zacks Investment Research   Sports Perspectives   - 25th May 17
Novogen Limited (ADR) (NVGN) Reaches $0.86 Yearly Low, Spf Beheer Bv Has Cut ...   UtahHerald.com   - 25th May 17
Novogen Patent Covering Anisina(TM) Has Proceeded to Grant   PR Newswire (press release)   - 14th Jun 16
Novogen Provides Update On Development Of Cantrixil   PR Newswire (press release)   - 02nd May 16
Trader's Buzz: Novogen Limited (NVGN), MagneGas Corp (MNGA), InterCloud ...   Wall Street Pit   - 08th May 15
Novogen Limited sinks 30%: Here's why   Motley Fool Australia   - 21st Apr 15
Novogen Announces Breakthrough Discovery in the Treatment of Melanoma   PR Newswire (press release)   - 16th Dec 14
Novogen Receives Funding Support To Commence Studies In Muscular Dystrophy   PR Newswire (press release)   - 12th Aug 14
Interactive Technical Analysis Chart Novogen Ltd ( NRT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Novogen Ltd
NRT Business Profile
Novogen Limited operates as a pharmaceutical drug development company worldwide. It focuses on the development of a family of anti-cancer drugs based on super-benzopyran and stealth drug technologies. The company’s lead drug candidate is CS-6, a mitochondrial electron transfer inhibitor for the treatment of temozolomide-resistant glioblastoma multiforme and late-stage chemo-refractory ovarian cancer. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.